(S (NP (NP (NP (NNP Alzheimer) (POS 's)) (NN disease)) (-LRB- -LRB-) (NP (NN AD)) (-RRB- -RRB-)) (VP (VBZ is) (NP (NP (DT the) (ADJP (RBS most) (JJ common)) (JJ neurodegenerative) (NN disease)) (PP (IN in) (NP (JJR older) (NNS people))))) (. .))
(S (PP (IN Despite) (NP (JJ considerable) (NNS efforts) (S (VP (TO to) (VP (VB find) (NP (NP (DT a) (NN cure)) (PP (IN for) (NP (NN AD))))))))) (, ,) (NP (EX there)) (VP (VBZ is) (NP (NP (DT a) (NML (CD 99.6) (NN %)) (NN failure) (NN rate)) (PP (IN of) (NP (JJ clinical) (NNS trials)))) (PP (IN for) (NP (NN AD) (NNS drugs))) (, ,) (ADJP (JJ likely)) (SBAR (IN because) (S (NP (NN AD) (NNS patients)) (VP (MD can) (RB not) (ADVP (RB easily)) (VP (VB be) (VP (VBN identified) (PP (IN at) (NP (JJ early) (NNS stages))))))))) (. .))
(S (NP (NP (DT This) (NN project)) (VP (VBN investigated) (NP (NN machine) (NN learning)))) (VP (VBZ approaches) (S (VP (TO to) (VP (VB predict) (NP (NP (DT the) (JJ clinical) (NN state)) (PP (IN of) (NP (NP (NNS patients)) (PP (IN in) (NP (JJ future) (NNS years)))))) (S (VP (TO to) (VP (VB benefit) (NP (NN AD) (NN research))))))))) (. .))
(S (NP (NP (JJ Clinical) (NNS data)) (PP (IN from) (NP (CD 1737) (NNS patients)))) (VP (VP (VBD was) (VP (VBN obtained) (PP (IN from) (NP (NP (DT the) (NNP Alzheimer) (POS 's)) (NML (NML (NNP Disease) (NNP Neuroimaging) (NNP Initiative)) (-LRB- -LRB-) (NML (NP (NNP ADNI))) (-RRB- -RRB-)) (NN database))))) (CC and) (VP (VBD was) (VP (VBN processed) (S (VP (VBG using) (NP (DT the) (`` ") (NML (NML (ADVP (RB All))) (PP (HYPH -) (NP (NNS Pairs)))) (`` ") (NN technique) (, ,) (DT a) (JJ novel) (NN methodology)) (S (VP (VBN created) (PP (IN for) (NP (NP (DT this) (NN project)) (PP (VBG involving) (NP (NP (DT the) (NN comparison)) (PP (IN of) (NP (NP (DT all) (JJ possible) (NNS pairs)) (PP (IN of) (NP (NP (NML (JJ temporal) (NNS data)) (NNS points)) (PP (IN for) (NP (DT each) (NN patient)))))))))))))))))) (. .))
(S (NP (DT This) (NN data)) (VP (VBD was) (ADVP (RB then)) (VP (VBN used) (S (VP (TO to) (VP (VB train) (NP (JJ various) (NML (NN machine) (NN learning)) (NNS models))))))) (. .))
(S (NP (NNS Models)) (VP (VP (VBD were) (VP (VBN evaluated) (S (VP (VBG using) (ADVP (RB 7-fold)) (NP (NP (NN cross-validation)) (PP (IN on) (NP (DT the) (NN training) (NN dataset)))))))) (CC and) (VP (VBD confirmed) (S (VP (VBG using) (NP (NNS data)) (PP (IN from) (NP (DT a) (JJ separate) (NN testing) (NN dataset)))))) (PRN (-LRB- -LRB-) (NP (CD 110) (NNS patients)) (-RRB- -RRB-))) (. .))
(S (NP (DT A) (JJ neural) (NN network) (NN model)) (VP (VBD was) (ADJP (ADJP (JJ effective) (PRN (-LRB- -LRB-) (S (NP (NN mAUC)) (VP (SYM =) (NP (CD 0.866)))) (-RRB- -RRB-))) (PP (PP (IN at) (S (VP (VBG predicting) (NP (NP (DT the) (NN progression)) (PP (IN of) (NP (NN AD)))) (PP (IN on) (NP (DT a) (NML (NML (NN month)) (HYPH -) (PP (IN by) (HYPH -) (NP (NN month)))) (NN basis)))))) (, ,) (CC both) (PP (IN in) (NP (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBD were) (UCP (NP (ADVP (RB initially)) (RB cognitively) (JJ normal)) (CC and) (PP (IN in) (NP (NNS patients)))))))) (VP (VBG suffering) (PP (IN from) (NP (JJ mild) (JJ cognitive) (NN impairment))))))))) (. .))
(S (NP (PDT Such) (DT a) (NN model)) (VP (MD could) (VP (VB be) (VP (VBN used) (S (VP (TO to) (VP (VB identify) (NP (NNS patients)) (PP (IN at) (NP (NP (NP (JJ early) (NNS stages)) (PP (IN of) (NP (NN AD)))) (CC and) (SBAR (WHNP (WP who)) (S (VP (VBP are) (ADVP (RB therefore)) (NP (NP (JJ good) (NNS candidates)) (PP (IN for) (NP (NP (JJ clinical) (NNS trials)) (PP (IN for) (NP (NN AD) (NNS therapeutics))))))))))))))))) (. .))
